Dr George Agulto Soriano, DMD in Newark, CA - Dentist

Dr George Agulto Soriano, DMD is a Dentist based in Newark, California. Dr George Agulto Soriano is licensed to practice in California (license number 43861) and his current practice location is 5853 Jarvis Ave, Newark, California. He can be reached at his office (for appointments etc.) via phone at (510) 744-6688.

NPI number for Dr George Agulto Soriano is 1386768802 and his current mailing address is 5853 Jarvis Ave, Newark, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1386768802.

Contact Information

	Dr George Agulto Soriano, DMD
	5853 Jarvis Ave, Newark, CA 94560-1251
	(510) 744-6688
	Not Available

Healthcare Provider's Profile

Full Name	Dr George Agulto Soriano
Gender	Male
Speciality	Dentist
Location	5853 Jarvis Ave, Newark, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1386768802
Provider Enumeration Date: 03/19/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr George Agulto Soriano such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1386768802	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
122300000X	Dentist	43861 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr George Agulto Soriano is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr George Agulto Soriano, DMD 5853 Jarvis Ave, Newark, CA 94560-1251 Ph: (510) 744-6688	Dr George Agulto Soriano, DMD 5853 Jarvis Ave, Newark, CA 94560-1251 Ph: (510) 744-6688

News Archive

Phase III GOG-212 clinical trial of CTI's OPAXIO for ovarian cancer: Enrollment to continue

Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.

Max Planck researchers obtain somatic stem cells from fully differentiated somatic cells

Breaking new ground, scientists at the Max Planck Institute for Molecular Biomedicine in M-nster, Germany, have succeeded in obtaining somatic stem cells from fully differentiated somatic cells. Stem cell researcher Hans Sch-ler and his team took skin cells from mice and, using a unique combination of growth factors while ensuring appropriate culturing conditions, have managed to induce the cells' differentiation into neuronal somatic stem cells.

Johns Hopkins cardiologists support use of statins for primary prevention of heart attack

Writing the first commentary for a new feature in the Journal of the American Medical Association (JAMA), called Viewpoint, Johns Hopkins cardiologists make the case for why a 55-year-old man with a 10 percent estimated risk of heart attack over the next 10 years should be offered statin medication. They were invited to debate a professor who argues against prescribing statins for "primary" prevention—for those who have not had a cardiovascular event, such as a heart attack—even though they may be considered at "intermediate" risk because of elevated cholesterol or other factors.

Central nervous system immune responses to COVID-19

A recent study published on the preprint server bioRxiv by scientists from Yale School of Medicine, University of California, Yale School of Public Health, Yale University, and Howard Hughes Medical Institute examined the impact of SARS-CoV-2 infection on the central nervous system.

Hudson Health Plan deploys Health Integrated Synergy Targeted Population Management program

Hudson Health Plan, a not-for-profit managed care organization that services New York's Hudson Valley, has selected Health Integrated, Inc., a leading provider of Health Management Solutions, as its partner to provide enhanced care management services for Medicaid members with co-morbid chronic illness.

Dentist in Newark, CA

Huang Kevin Cheng, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 5866 Mowry School Rd, Newark, CA 94560 Phone: 510-656-4400 Fax: 510-656-4494
Dr. Mehrnoosh Moghaddam, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 7332 Thornton Ave, Newark, CA 94560 Phone: 510-796-3333 Fax: 510-796-3480
Thomas Wong, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1131 Newpark Mall, Newark, CA 94560 Phone: 510-796-8888 Fax: 510-796-0397
Dr. Mohsen Forghany, DDS Dentist Medicare: Medicare Enrolled Practice Location: 37070 Newark Blvd Ste C, Newark, CA 94560 Phone: 510-797-2840
Dr. Alberto F. Sandoval, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6170 Thornton Ave Ste B, Newark, CA 94560 Phone: 510-378-5306 Fax: 510-509-7768
Grace Lacson Del Rosario, Dentist Medicare: Not Enrolled in Medicare Practice Location: 35111 Newark Blvd Ste A, Newark, CA 94560 Phone: 510-494-0404 Fax: 510-494-1621
Dr. Scott Hien Gia Nguyen, Dentist Medicare: Medicare Enrolled Practice Location: 6180 Jarvis Ave, Suite J, Newark, CA 94560 Phone: 510-795-9669 Fax: 510-795-1404

Dr George Agulto Soriano, DMD - Dentist in Newark, CA